ARCHIVES

Phase II Study Meets Primary Endpoint, Demonstrating Overall Survival of 5.2 Months

This article is from The Cancer Letter archive.

Vol. 36 No. 9 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

Vaccine Increases PFS by 4 Months In Phase II Per-Protocol Analysis

June 27, 2014

Turmoil in Texas: DePinho Recommended AVEO Stock on CNBC Six Days After FDA Said New Trial Was Needed

May 10, 2013

Center Directors To Rewrite 5-Year Plan With Little Staff Help

March 9, 1990

Cancer Society, Centers Explore Collaboration On Public Issued, Education, Information Activities

January 25, 1991

ASCO Seeks “Nothing Less Than A Smoke-Free World”

June 6, 2003

In Brief: Senate Committee Finishes Work On Renewal Bill, Both Houses (So Far) Leave NCI Authorities Intact

May 21, 1982